Is Asprin the next wonder drug to treat cancer?
The various benefits and importance of Asprin are
known to all. It is a lifesaving drug for people who had experienced a heart
attack in the past and saved one from other cardiovascular
diseases. However, a recent
survey in the US revealed that the pill has been widely used among the elderly
as a preventive measure. This is a matter of concern as the US Food and Drug
Administration doesn’t recommend taking the pill by people who had not suffered
from a heart attack in the past. (Read: Prevent
heart disease by following the Mediterranean diet)
In this survey of more than 2,500
respondents aged 45-75, 52 percent reported current aspirin use. The FDA has
determined that Asprin can be used primarily to prevent a first heart attack or
stroke, for every such event that’s prevented, there’s approximately one major
bleeding event that’s caused, such as gastrointestinal bleeding. Ever since
aspirin was invented in Germany in 1897, it has been used to treat a wide range
of ailments – from headache to inflammation and as a means to stop the possible
cardiovascular events. In 2013, some studies came out with the news that it may
also prevent some cancers, particularly bowel
cancer. This is the reason for increased interest among the elderly
to use the drug. ‘The use of aspirin is still a very
contentious issue among medical experts. The support of its use in primary
prevention is more of a mixed bag,’ said lead author Craig Williams from the
Oregon State University. (Read: 10
simple tips to prevent heart disease)
Is it safe
The link between aspirin and cancer was
found in 7 trials on 23,000 people who were given it to monitor prevention of
strokes and heart attacks, besides cancer.
The results showed a link between aspirin and a 34 percent reduction in deaths
from all cancers and a 54 percent reduction in gastrointestinal cancer. ‘But this survey clearly shows that more and
more people who have not experienced those events and are not technically
considered at high risk by the FDA are also deciding to use aspirin, usually in
consultation with their doctors,’ Williams added.
There were also benefits in terms of
oesophageal, lung pancreatic andprostate
cancers. But, the participants had to have been on aspirin for at
least five years to get these benefits, said the 2003 study. However, there was
also an increase in the side effects of aspirin, like bleeding both into the
bowel and brain, said researchers recently. (Read: Men
can lower their risk of bowel cancer with healthy lifestyles)
But this practise isn’t recommended by the
FDA, and hence shouldn’t be done to avoid other consequences.
With inputs from IANS.
Comments
Post a Comment